Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review
Main Authors: | DA Lane, S Raichand, D Moore, M Connock, A Fry-Smith, DA Fitzmaurice |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2013-07-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta17300 |
Similar Items
-
Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Goto, Koji
Published: (2015) -
ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION?
by: D. A. Napalkov, et al.
Published: (2016-05-01) -
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation
by: Romain Chopard, et al.
Published: (2018-04-01) -
Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
by: Kang-Ho Choi, et al.
Published: (2021-05-01) -
Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)